摘要
目的比较研究药学类(药学、中药学)“双一流”建设高校药理学与毒理学学科竞争力和发展水平,系统总结分析各高校发展特色和不足,以期为药学类世界一流学科建设提供决策参考。方法以入选药学和中药学“双一流”建设的13所高校为研究对象,运用InCite数据库中各项文献计量指标从学科生产力、学科影响力和学科发展力3个方面综合比较各高校的学科发展(2011产力、学科年)进步度。结果13所高校药理学与毒理学学科总体呈增长趋势,其中中医药高校的学科生产力提高明显,中国药科大学的科研实力和影响力整体提升较大,中山大学和北京大学在科研发展力上表现突出。与此同时,13所高校在学科研究广度、深度、学科引领作用等方面与距离世界一流学科仍存在一定差距。结论在当前“破五唯”、论文“SCI至上”的背景下,学科发展要回归学术本质,要逐步探索实现从“指标一流”向“内涵一流”转变,加强学科间的交叉融合,服务国家战略和行业区域发展需求。
Objective This paper aims to analyse and discuss the progressive rate of competitive ability and the development level of 13 first-class pharmaceutical and traditional Chinese pharmacology disciplines constructed universities in Pharmacology and Toxicology between 2011 to 2020.And summarize the superiorities,disadvantages and characteristics,analyze the existing problems.We hope it will provide a reference for the development planning and decision-making.Methods According to bibliometric analysis method,We take 13 first-class pharmaceutical and traditional Chinese pharmacology disciplines constructed universities as the research objects.Based on the InCites platform,we selected the literature of pharmacology and toxicology collected from WoS database between 2011 to 2020,we statistically analyze and contrast the progressive rate from the aspects of the productivity,influence,and the discipline development.Results The progressive rate of 13 constructed universities show a rising trend.And the discipline productivities of the universities of traditional Chinese medicine are improved significantly.The research capability and discipline influence of China Pharmaceutical University are promoted on the whole.Sun Yat Sen University and Peking University have outstanding performances in the discipline development.But there still exists many problems in research range,research depth and discipline leading.These is a heavy responsibility and a long course to support the world-class discipline development and construction.Conclusion In nowadays background,the discipline development should return to essence,we should pay more and more attention to the qualities of the achievements in scientific research while increasing the quantities.We should promote the leading role of the discipline,enhance the cross fusion between different disciplines.As a breakthrough in building the world first-class disciplines,we should seize the opportunity,and stride forward to the goal of world-class universities and first-class disciplines.
作者
刘颖
苌雅娴
丁佐奇
郑晓南
许风国
LIU Ying;CHANG Yaxian;DING Zuoqi;ZHENG Xiaonan;XU Fengguo(Editorial Office of Chinese Journal of Natural Medicines,China Pharmaceutical University,Nanjing 210009,China;Department of Development Planning and Disciplinary Construction,China Pharmaceutical University,Nanjing 211198,China)
出处
《药学研究》
CAS
2021年第1期62-67,共6页
Journal of Pharmaceutical Research
基金
中央高校基本科研业务费专项资金资助(No.2632020PY10)
江苏科技期刊研究基金(No.JSRFSTP2019C03)
中国科技期刊卓越行动计划(No.卓越计划-C-172)
江苏省学位与研究生教育学会学位授予质量研究课题(No.XYH012)。
关键词
药学
中药学
一流学科
文献计量学
学科进步度
First-class disciplines
Bibliometric analysis
Progressive rate of discipline